In the SURMOUNT-1 trial, people treated with tirzepatide lost up to 22.5% of their body weight over 72 weeks , making it even more effective than semaglutide (NEJM tirzepatide study)
Chronic migraine responding to intravenous thiamine: a report of two cases
For Safety: Ensure the peptides are out of reach of small children
These solutions help maintain sterility, safety, and consistency in medical and aesthetic treatments
As always: work with a qualified practitioner who knows how to source it legally, dose it, monitor labs, and integrate it into a real, comprehensive health plan
However, the data can be made available from the authors upon reasonable request and with permission of Sanofi